Skip to main content
Top
Published in: BMC Cancer 1/2021

01-12-2021 | Rectal Cancer | Research

Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway

Authors: Yngvar Nilssen, Morten Tandberg Eriksen, Marianne G. Guren, Bjørn Møller

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

International differences in survival among colorectal cancer (CRC) patients may partly be explained by differences in emergency presentations (EP), waiting times and access to treatment.

Methods

CRC patients registered in 2015–2016 at the Cancer Registry of Norway were linked with the Norwegian Patient Registry and Statistics Norway. Multivariable logistic regressions analysed the odds of an EP and access to surgery, radiotherapy and systemic anticancer treatment (SACT). Multivariable quantile regression analysed time from diagnosis to treatment.

Results

Of 8216 CRC patients 29.2% had an EP before diagnosis, of which 81.4% were admitted to hospital with a malignancy-related condition. Higher age, more advanced stage, more comorbidities and colon cancer were associated with increased odds of an EP (p < 0.001). One-year mortality was 87% higher among EP patients (HR=1.87, 95%CI:1.75–2.02). Being married or high income was associated with 30% reduced odds of an EP (p < 0.001). Older age was significantly associated with increased waiting time to treatment (p < 0.001). Region of residence was significantly associated with waiting time and access to treatment (p < 0.001). Male (OR = 1.30, 95%CI:1.03,1.64) or married (OR = 1.39, 95%CI:1.09,1.77) colon cancer patients had an increased odds of SACT. High income rectal cancer patients had an increased odds (OR = 1.48, 95%CI:1.03,2.13) of surgery.

Conclusion

Patients who were older, with advanced disease or more comorbidities were more likely to have an emergency-onset diagnosis and less likely to receive treatment. Income was not associated with waiting time or access to treatment among CRC patients, but was associated with the likelihood of surgery among rectal cancer patients.
Appendix
Available only for authorised users
Literature
2.
go back to reference Cancer Registry of Norway. Cancer in Norway 2019 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo, Cancer Registry of Norway; 2020. Cancer Registry of Norway. Cancer in Norway 2019 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo, Cancer Registry of Norway; 2020.
4.
go back to reference Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta oncologica (Stockholm, Sweden). 2010;49(5):725–36.CrossRef Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta oncologica (Stockholm, Sweden). 2010;49(5):725–36.CrossRef
5.
go back to reference Skyrud KD, Bray F, Eriksen MT, Nilssen Y, Møller B. Regional variations in cancer survival: impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway. International Journal of Cancer Journal international du cancer. 2016;138(9):2190–200. https://doi.org/10.1002/ijc.29967.CrossRefPubMed Skyrud KD, Bray F, Eriksen MT, Nilssen Y, Møller B. Regional variations in cancer survival: impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway. International Journal of Cancer Journal international du cancer. 2016;138(9):2190–200. https://​doi.​org/​10.​1002/​ijc.​29967.CrossRefPubMed
12.
go back to reference Cavalli-Björkman N, Lambe M, Eaker S, Sandin F, Glimelius B. Differences according to educational level in the management and survival of colorectal cancer in Sweden. European Journal of Cancer (Oxford, England : 1990). 2011;47(9):1398–406.CrossRef Cavalli-Björkman N, Lambe M, Eaker S, Sandin F, Glimelius B. Differences according to educational level in the management and survival of colorectal cancer in Sweden. European Journal of Cancer (Oxford, England : 1990). 2011;47(9):1398–406.CrossRef
14.
go back to reference Hsieh MC, Chiu YW, Velasco C, Wu XC, O'Flarity MB, Chen VW. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer. J Registry Manag. 2013;40(4):180–7.PubMed Hsieh MC, Chiu YW, Velasco C, Wu XC, O'Flarity MB, Chen VW. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer. J Registry Manag. 2013;40(4):180–7.PubMed
15.
go back to reference Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. European Journal of Cancer (Oxford, England : 1990). 2009;45(7):1218–31.CrossRef Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. European Journal of Cancer (Oxford, England : 1990). 2009;45(7):1218–31.CrossRef
16.
go back to reference Kastpersen S, Kalseth B. Omfang og Utvikling av det Selv-betalende Markedet for private Spesialisthelsetjenester i Norge [scope and development of the private spending on healthcare for private healthcare in Norway]. SINTEF: Trondheim; 2010. Kastpersen S, Kalseth B. Omfang og Utvikling av det Selv-betalende Markedet for private Spesialisthelsetjenester i Norge [scope and development of the private spending on healthcare for private healthcare in Norway]. SINTEF: Trondheim; 2010.
22.
go back to reference Hosmer DW, Lemeshow S. Applied logistic regression. Second ed. New York: Wiley-Interscience Publication; 2005. Hosmer DW, Lemeshow S. Applied logistic regression. Second ed. New York: Wiley-Interscience Publication; 2005.
24.
go back to reference StataCorp. Stata statistical software: release 16. College Station, TX: StataCorp LLC; 2019. StataCorp. Stata statistical software: release 16. College Station, TX: StataCorp LLC; 2019.
25.
go back to reference Nesbakken A, Gaard M. Surgical treatment of colon cancer. Tidsskr Nor Laegeforen. 2007;127(22):2942–5.PubMed Nesbakken A, Gaard M. Surgical treatment of colon cancer. Tidsskr Nor Laegeforen. 2007;127(22):2942–5.PubMed
28.
go back to reference Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, et al. Age disparities in stage-specific colon cancer survival across seven countries: an ICBP SURVMARK-2 population-based study. International Journal of Cancer Journal international du cancer. 2020. Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, et al. Age disparities in stage-specific colon cancer survival across seven countries: an ICBP SURVMARK-2 population-based study. International Journal of Cancer Journal international du cancer. 2020.
30.
go back to reference Nasjonalt kvalitetsregister for tykk- og endetarmskreft. Årsrapport 2019 med resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for tykk- og endetarmskreft. Kreftregisteret; 2020. Nasjonalt kvalitetsregister for tykk- og endetarmskreft. Årsrapport 2019 med resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for tykk- og endetarmskreft. Kreftregisteret; 2020.
32.
go back to reference Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22–40.CrossRefPubMed Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22–40.CrossRefPubMed
34.
go back to reference Åsli LM, Myklebust T, Kvaløy SO, Jetne V, Møller B, Levernes SG, et al. Factors influencing access to palliative radiotherapy: a Norwegian population-based study. Acta oncologica (Stockholm, Sweden). 2018;57(9):1250–8.CrossRef Åsli LM, Myklebust T, Kvaløy SO, Jetne V, Møller B, Levernes SG, et al. Factors influencing access to palliative radiotherapy: a Norwegian population-based study. Acta oncologica (Stockholm, Sweden). 2018;57(9):1250–8.CrossRef
Metadata
Title
Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway
Authors
Yngvar Nilssen
Morten Tandberg Eriksen
Marianne G. Guren
Bjørn Møller
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08415-1

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine